Eli Lilly & Co.
LLY XNYS
$1347.11
-4.01 (-0.30%)
▼
15-min delayed
Open
$1362.38
High
$1372.05
Low
$1341.76
Volume
3.55M
Market Cap
$1.20T
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Earnings & Analyst Ratings
Next Earnings:
Tue, Feb 2, 2027
Calendar →
TickerDaily Coverage
Stock Market Today, October 29, 2026: S&P 500 Closes Near Flat on Earnings Deluge
Market News
Sarah Mitchell · Oct 29, 2026
The stock market today finished with mixed signals on Thursday, October 29, 2026, as a wave of...
Stock Market Today, October 18, 2026: Week Ahead Preview — Tech Earnings Dominate
Market News
David Brooks · Oct 19, 2026
The stock market heads into a pivotal earnings week with major tech and industrial names reporting....
Healthcare Stocks This Week: XLV Outpaces S&P 500 Amid Rate Pause Optimism (Oct 5–9, 2026)
Market News
David Brooks · Oct 9, 2026
The healthcare sector navigated a volatile week with conviction, as the XLV ETF gained 2.8% from...
Pre-Market Stock Movers: Top 5 Biggest Gainers and Losers Before the Bell Today
Market News
Sarah Mitchell · Aug 28, 2026
Five major stocks are making outsized moves in pre-market trading Friday, August 28, 2026, ahead of...
Pre-Market Movers Today: Top 5 Stocks Making Biggest Moves Before the Bell (August 21, 2026)
Market News
Sarah Mitchell · Aug 21, 2026
Before the opening bell on Friday, August 21, 2026, five major stocks are making significant...
View All Coverage →
Get LLY Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Eli Lilly & Co..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.